Sleep Medicine Reviews
Volume 13, Issue 6 , Pages 385-401, December 2009

The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases

  • Alex Iranzo

      Affiliations

    • Corresponding Author InformationCorresponding author. Neurology Service, Hospital Clínic de Barcelona, C/Villarroel 170, Barcelona 08036, Spain. Fax: +34 932275783.
  • ,
  • Joan Santamaria

      Affiliations

    • Present address: Neurology Service, Hospital Clínic de Barcelona, C/Villarroel 170, Barcelona 08036, Spain. Fax: +34 932275783. jsantama@clinic.ub.es.
  • ,
  • Eduard Tolosa

      Affiliations

    • Present address: Neurology Service, Hospital Clínic de Barcelona, Barcelona 08036, Spain. Fax: +34 932275783. etolosa@clinic.ub.es.

Neurology Service, Hospital Clínic and Institut d'Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain

Summary 

REM sleep behavior disorder (RBD) is characterized by vigorous movements associated with unpleasant dreams and increased electromyographic activity during REM sleep. Polysomnography with audiovisual recording is needed to confirm the diagnosis of RBD and to exclude other sleep disorders that can mimic its symptoms including obstructive sleep apnea, nocturnal hallucinations and confusional awakenings. RBD may be idiopathic or related to neurodegenerative diseases, particularly multiple system atrophy, Parkinson's disease and dementia with Lewy bodies. RBD may be the first manifestation of these disorders, antedating the onset of parkinsonism, cerebellar syndrome, dysautonomia, and dementia by several years. RBD should thus be considered an integral part of the disease process. When effective, neuroprotective strategies should be considered in subjects with idiopathic RBD. Patients with other neurodegenerative diseases, though, such as spinocerebellar ataxias, may also present with RBD. When clinically required, clonazepam at bedtime is effective in decreasing the intensity of dream-enacting behaviors and unpleasant dreams in both the idiopathic and secondary forms. When part of a neurodegenerative disorder the development of RBD is thought to reflect the location and extent of the underlying lesions involving the REM sleep centers of the brain (e.g., locus subceruleus, amygdala, etc.), leading to a complex multiple neurotransmitter dysfunction that involves GABAergic, glutamatergic and monoaminergic systems. RBD is mediated neither by direct abnormal alpha-synuclein inclusions nor by striatonigral dopaminergic deficiency alone.

Keywords: REM sleep, REM sleep behavior disorder, Neurodegenerative diseases, Multiple system atrophy, Dementia with Lewy bodies, Parkinson's disease

Abbreviations: AD, Alzheimer disease, DLB, dementia with Lewy bodies, IRBD, idiopathic rapid eye movement sleep behavior disorder, MSA, multiple system atrophy, PD, Parkinson's disease, PDD, Parkinson's disease associated with dementia, PSG, polysomnography, RBD, rapid eye movement sleep behavior disorder, REM, rapid eye movement, VPSG, videopolysomnography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1087-0792(08)00129-9

doi:10.1016/j.smrv.2008.11.003

Sleep Medicine Reviews
Volume 13, Issue 6 , Pages 385-401, December 2009